METASTATIC
Clinical trials for METASTATIC explained in plain language.
Never miss a new study
Get alerted when new METASTATIC trials appear
Sign up with your email to follow new studies for METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo aims to wipe out hidden cancer cells in triple negative breast cancer
Disease control Recruiting nowThis study tests a combination of two drugs, sarilumab and capecitabine, in people with aggressive breast cancer (triple negative or hormone-resistant). The goal is to eliminate tiny amounts of cancer that remain after standard treatment, which can lead to deadly spread. About 65…
Matched conditions: METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 16, 2026 23:32 UTC
-
Two-Drug combo aims to control tough lung cancer
Disease control Recruiting nowThis study tests the safety and effectiveness of combining two drugs, lorlatinib and ramucirumab, for people with advanced ALK-rearranged non-small cell lung cancer. Researchers will first find a dose that causes few side effects, then see if that dose helps control the cancer. U…
Matched conditions: METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 16, 2026 23:32 UTC
-
New hope for rare gut cancers: drug combo shows promise in early trial
Disease control Recruiting nowThis study tests a combination of three drugs (surufatinib, sintilimab, and capecitabine) in people with advanced small bowel or appendix cancer that has spread and not responded to prior treatment. The goal is to see if this combination can shrink tumors or slow cancer growth. A…
Matched conditions: METASTATIC
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New CAR-T therapy targets tough cancers with double precision
Disease control Recruiting nowThis study tests a new treatment for adults with advanced solid cancers that have not responded to standard therapies. The treatment uses a patient's own immune cells, modified to attack two cancer targets at once, chosen based on each tumor's unique markers. The goal is to impro…
Matched conditions: METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated May 14, 2026 12:02 UTC